Literature DB >> 29596626

Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates.

Antonio La Marca1, Christophe Blockeel2, Ernesto Bosch3, Renato Fanchin4, Human M Fatemi5, Bart C Fauser6, Juan A García-Velasco7, Peter Humaidan8, Basil C Tarlatzis9, Scott M Nelson10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29596626     DOI： 10.1093/humrep/dey061

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  8 in total

Review 1.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

Review 2.  Management Strategies for POSEIDON Groups 3 and 4.

Authors:  Thor Haahr; Carlos Dosouto; Carlo Alviggi; Sandro C Esteves; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-11       Impact factor: 5.555

3.  A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study.

Authors:  Bum Chae Choi; Canquan Zhou; Hong Ye; Yun Sun; Ying Zhong; Fei Gong; Ivan Sini; Nadezda Abramova; Salvatore Longobardi; Miranda Hickey; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2022-01-17       Impact factor: 5.211

Review 4.  Self-Monitoring of Urinary Hormones in Combination with Telemedicine - a Timely Review and Opinion Piece in Medically Assisted Reproduction.

Authors:  Roger J Hart; Thomas D'Hooghe; Eline A F Dancet; Ramón Aurell; Bruno Lunenfeld; Raoul Orvieto; Antonio Pellicer; Nikolaos P Polyzos; Wenjing Zheng
Journal:  Reprod Sci       Date:  2021-11-15       Impact factor: 2.924

5.  Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders.

Authors:  Jori A Leijdekkers; Helen L Torrance; Nienke E Schouten; Theodora C van Tilborg; Simone C Oudshoorn; Ben Willem J Mol; Marinus J C Eijkemans; Frank J M Broekmans
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918

6.  The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review.

Authors:  Erica Velthuis; Julie Hubbard; Salvatore Longobardi; Thomas D'Hooghe
Journal:  Adv Ther       Date:  2020-10-15       Impact factor: 3.845

Review 7.  The POSEIDON stratification - moving from poor ovarian response to low prognosis.

Authors:  Matheus Roque; Thor Haahr; Sandro C Esteves; Peter Humaidan
Journal:  JBRA Assist Reprod       Date:  2021-04-27

8.  Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database.

Authors:  Mary C Mahony; Brooke Hayward; Gilbert L Mottla; Kevin S Richter; Stephanie Beall; G David Ball; Thomas D'Hooghe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.